Innovation
2 patent families (1 granted) — focus: Human necessities; filing pace steady. Cited 27 times.
| Year | Filings |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 1 |
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |
Developer of peptide-based drugs to treat cartilage defects
2 patent families (1 granted) — focus: Human necessities; filing pace steady. Cited 27 times.
| Year | Filings |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 1 |
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |